Código QR

KDM6B inhibition enhances chemotherapeutic response in small cell lung cancer via epigenetic regulation of apoptosis and ferroptosis

Abstract Background Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression and the frequent emergence of resistance to standard chemotherapeutic agents such as cisplatin (DDP) and etoposide (VP16), resulting in poor clinical outcomes. Methods and results T...

Descrición completa

Gardado en:
Principais autores: Zhongliang Wang, Ziyuan Liu, Yufan Yang, Wenyang Wang, Qian Chen, Shumei Liang, Linlang Guo, Man Li
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2025-11-01
Series:Cell & Bioscience
Assuntos:
Small cell lung cancer
Chemotherapy resistance
KDM6B
KDM6B/ERG3/c-FOS axis
Drug combination
Acceso en liña:https://doi.org/10.1186/s13578-025-01496-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares